Literature DB >> 20182811

Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes?

Masanori Tokunaga1, Shigekazu Ohyama, Naoki Hiki, Tetsu Fukunaga, Susumu Aikou, Toshiharu Yamaguchi.   

Abstract

BACKGROUND: The prognosis of patients with gastric cancer and para-aortic lymph node (PALN) metastasis is poor. Recent Japanese randomized trials concluded that prophylactic PALN dissection is not effective for curable advanced gastric cancer. However, the value of curative resection in patients with pathologically positive PALN is not determined yet.
METHODS: We retrospectively identified 178 patients with pathologically positive PALN who underwent curative resection at the Cancer Institute Hospital from 1980 to 2004. Patient characteristics were analyzed and independent prognostic factors for death were identified by Cox proportional hazard model.
RESULTS: Partial gastrectomy was the most frequently performed procedure (142 of 178). Postoperative morbidity and mortality rates were 30 and 2%, respectively, with a 5-year survival rate of 13.0%. Multivariate analysis revealed the total number of positive nodes (hazard ratio, 1.804; 95% confidence interval, 1.221-2.665) and macroscopic type (hazard ratio, 1.697; 95% confidence interval, 1.138-2.530) as independent prognostic factors, while age, sex, histology, pathological tumor depth, and degree of PALN dissection were not statistically significant. The 5-year survival rate increased to 28.6% in patients with < or =15 positive nodes and macroscopic type other than type 4.
CONCLUSIONS: Prophylactic PALN dissection can not be justified in curable advanced gastric cancer. However, R0 resection including PALN retrieval might be beneficial in patients with pathologically positive PALN, providing patients are carefully selected and operations are performed safely.

Entities:  

Mesh:

Year:  2010        PMID: 20182811     DOI: 10.1245/s10434-010-0969-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

Review 1.  Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?

Authors:  Yasuhiro Kodera; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

Review 2.  Lymphadenectomy: state of the art.

Authors:  Daniele Marrelli; Lorenzo De Franco; Livio Iudici; Karol Polom; Franco Roviello
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-17

Review 3.  Clinical impact of molecular classifications in gastric cancer.

Authors:  Daniele Marrelli; Karol Polom; Alessandro Neri; Franco Roviello
Journal:  Updates Surg       Date:  2018-05-23

Review 4.  Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives.

Authors:  Valentina Mengardo; Maria Bencivenga; Jacopo Weindelmayer; Michele Pavarana; Simone Giacopuzzi; Giovanni de Manzoni
Journal:  Updates Surg       Date:  2018-05-30

5.  Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis.

Authors:  Masanori Tokunaga; Masanori Terashima; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Hirofumi Yasui; Narikazu Boku
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

Review 6.  Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy.

Authors:  Takaki Yoshikawa; Yasushi Rino; Norio Yukawa; Takashi Oshima; Akira Tsuburaya; Munetaka Masuda
Journal:  Surg Today       Date:  2013-03-19       Impact factor: 2.549

Review 7.  Gastric cancer: Current status of lymph node dissection.

Authors:  Maurizio Degiuli; Giovanni De Manzoni; Alberto Di Leo; Domenico D'Ugo; Erica Galasso; Daniele Marrelli; Roberto Petrioli; Karol Polom; Franco Roviello; Francesco Santullo; Mario Morino
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

8.  Role of Surgery in the Management for Gastric Cancer with Synchronous Distant Metastases.

Authors:  Masahide Ikeguchi; Kozo Miyatani; Seigo Takaya; Tomoyuki Matsunaga; Youji Fukumoto; Tomohiro Osaki; Hiroaki Saito; Toshiro Wakatsuki
Journal:  Indian J Surg Oncol       Date:  2015-07-01

9.  Is There Any Role for D3 Lymphadenectomy in Gastric Cancer?

Authors:  Gerassimos N Douridas; Stefanos K Pierrakakis
Journal:  Front Surg       Date:  2018-03-22

10.  Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis.

Authors:  Jingyu Deng; Dan Sun; Yuan Pan; Li Zhang; Rupeng Zhang; Dianchang Wang; Xishan Hao; Han Liang
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.